Keryx Biopharmaceuticals Aktie
WKN: 940772 / ISIN: US4925151015
05.11.2013 00:51:25
|
Keryx Biopharma Q3 Loss Widens
(RTTNews) - Keryx Biopharmaceuticals, Inc.(KERX) posted third-quarter net loss of $15.7 million or $0.19 per share, wider than $5.5 million or $0.08 per share in the comparable quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.11 per share. Analysts' estimates typically exclude special items.
The company did not generate any revenues for both the quarters.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Keryx Biopharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |